119-SRES-669 Working Poor Impact Perspective

1) Summary of my opinion of the bill

- This is a simple Senate resolution—nonbinding, no new money, no new mandates. So it won’t move my monthly budget by itself. ([senate.gov](https://www.senate.gov/about/research-tools/glossary.htm?utm_source=openai))

- That said, blood clots are a big, preventable, and costly problem. If the attention pushes hospitals, insurers, and employers to tighten prevention and education, families like mine could avoid a surprise ER bill and weeks off work. ([cdc.gov](https://www.cdc.gov/blood-clots/data-research/facts-stats/index.html?utm_source=openai))

2) Specific impacts (good/bad) on what I care about

• Out‑of‑pocket healthcare costs (near term): No automatic change. But awareness could prompt hospitals to enforce VTE prevention bundles and discharge education; preventing one clot can avert a costly hospitalization and months of pricey anticoagulants. ([cdc.gov](https://www.cdc.gov/blood-clots/data-research/facts-stats/index.html?utm_source=openai))
• Drug costs if I (or a parent) need blood thinners: The resolution itself doesn’t cap prices, but for seniors the Medicare Part D out‑of‑pocket cap is now indexed (about $2,100 in 2026), which limits worst‑case spending on meds like apixaban or rivaroxaban. ([cms.gov](https://www.cms.gov/newsroom/fact-sheets/2026-medicare-advantage-part-d-advance-notice-fact-sheet?utm_source=openai))
• Income and time off work: Avoiding a clot avoids missed shifts and lost pay; awareness that clots strike after surgery, during cancer treatment, and post‑pregnancy can keep workers from ignoring symptoms. ([cdc.gov](https://www.cdc.gov/blood-clots/data-research/facts-stats/index.html?utm_source=openai))
• Community impact: Clots are a leading cause of preventable hospital death; clearer signage, risk checklists, and mobility reminders in hospitals could save lives—especially for high‑risk groups (cancer patients; during/after pregnancy). ([cdc.gov](https://www.cdc.gov/blood-clots/data-research/facts-stats/index.html?utm_source=openai))
• Vulnerable populations I worry about: New parents face elevated clot risk for up to 3 months after delivery—postpartum counseling and coverage for follow‑up could prevent tragedies in households already stretched thin. ([cdc.gov](https://www.cdc.gov/blood-clots/toolkit/pregnancy-infographic.html?utm_source=openai))
• Fairness angle: Hospitals and large employers can implement low‑cost steps (risk screening, movement breaks on long shifts, travel policies) with minimal burden; ordinary workers shouldn’t carry the medical and financial fallout alone. (Awareness helps only if institutions act.)
• Environmental/sustainability: Not really applicable; this is about clinical prevention and patient education, with negligible environmental effects.

Long‑term vs short‑term effects

• Short term (next 3–12 months): Mostly messaging. Best‑case, hospital units refresh VTE prevention checklists and postpartum discharge materials; that could reduce a slice of preventable readmissions and copays. ([cdc.gov](https://www.cdc.gov/blood-clots/data-research/facts-stats/index.html?utm_source=openai))
• Long term (multi‑year): If awareness sustains policy changes (quality measures tied to VTE prevention, better insurer coverage of outpatient follow‑up), households could see fewer medical crises and lower cumulative costs—important since blood clots cost the U.S. up to $10B a year. ([cdc.gov](https://www.cdc.gov/blood-clots/toolkit/impact-of-blood-clots.html?utm_source=openai))

Unintended consequences to watch

• Cost without benefit: Awareness alone can prompt more low‑yield testing if systems don’t pair it with risk‑based protocols—driving up deductibles with little health gain. (Use clinical risk tools, not blanket ultrasounds.)
• Equity gaps: If follow‑through materials aren’t multilingual or postpartum supports are spotty, high‑risk families may miss the message—undercutting the goal even as the hospital looks compliant.
• Complacency risk: Lawmakers may point to this resolution instead of funding proven prevention programs (nurses’ time for mobility rounds, discharge counseling). The resolution itself doesn’t supply resources. ([senate.gov](https://www.senate.gov/about/research-tools/glossary.htm?utm_source=openai))

Key numbers that matter for households (not GDP)

Sources: CDC data and toolkits (incidence, deaths, and preventable‑death status) and CMS guidance on the 2026 Part D out‑of‑pocket cap. ([cdc.gov](https://www.cdc.gov/blood-clots/data-research/facts-stats/index.html?utm_source=openai))

4) Bottom line: My stance

I view this resolution favorably—as a low‑cost nudge that could save families grief and big medical bills—but it’s only a nudge. To matter for my wallet, it needs follow‑through: hospital prevention protocols, postpartum education, and insurer/employer policies that make movement breaks and risk screening standard on the job. The resolution itself doesn’t spend a dime or change coverage; the real test is what institutions do next. ([senate.gov](https://www.senate.gov/about/research-tools/glossary.htm?utm_source=openai))